Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
35
Frequently Asked Questions
What is Market Cap of Kiromic BioPharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kiromic BioPharma Inc market cap is $3.97M.
What is the 52-week high for Kiromic BioPharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kiromic BioPharma Inc 52 week high is $8.97 as of September 28, 2025.
What is the 52-week low for Kiromic BioPharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kiromic BioPharma Inc 52 week low is $0.16 as of September 28, 2025.
What is Kiromic BioPharma Inc stock price today?
Kiromic BioPharma Inc stock price today is $2.31.
What was Kiromic BioPharma Inc stock price yesterday?
Kiromic BioPharma Inc stock price yesterday was $3.08.
What is the PE ratio of Kiromic BioPharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kiromic BioPharma Inc’s P/E ratio is -0.14.
What is the Price-to-Book ratio of Kiromic BioPharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kiromic BioPharma Inc P/B ratio is -0.4250.
What is Kiromic BioPharma Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Kiromic BioPharma Inc's EBITDA is -0.79.
What is the 50-day moving average of Kiromic BioPharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kiromic BioPharma Inc 50-day moving average is $2.70.
How many employess does Kiromic BioPharma Inc has?